RedHill Biopharma (RDHL) Posts Q3 Loss of 7c/Share

RedHill Biopharma (NASDAQ: RDHL) reported Q3 EPS of ($0.07), $0.51 better than the analyst estimate of ($0.58).

For earnings history and earnings-related data on RedHill Biopharma (RDHL) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown